JAZZ
Jazz Pharmaceuticals PLCNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$11.75B
P/E Ratio
—
EPS
$-5.85
Beta
0.23
52W High
$198.00
52W Low
$96.28
50-Day MA
$177.44
200-Day MA
$147.85
Dividend Yield
—
Profit Margin
-8.35%
Forward P/E
7.92
PEG Ratio
0.60
About Jazz Pharmaceuticals PLC
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and markets pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company is headquartered in Dublin, Ireland.
Fundamentals
| Revenue (TTM) | $4.27B |
| Gross Profit (TTM) | $3.91B |
| EBITDA | $1.71B |
| Operating Margin | 27.10% |
| Return on Equity | -8.47% |
| Return on Assets | 5.38% |
| Revenue/Share (TTM) | $69.98 |
| Book Value | $70.30 |
| Price-to-Book | 2.67 |
| Price-to-Sales (TTM) | 2.75 |
| EV/Revenue | 3.396 |
| EV/EBITDA | 55.00 |
| Quarterly Earnings Growth (YoY) | 3.20% |
| Quarterly Revenue Growth (YoY) | 10.10% |
| Shares Outstanding | $61.56M |
| Float | $59.62M |
| % Insiders | 3.08% |
| % Institutions | 102.89% |
Analyst Ratings
Consensus ($223.50 target)
5
Strong Buy9
Buy2
HoldData last updated: 4/8/2026